The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA
Ultromics
Applies artificial intelligence to echocardiograms for automated heart failure diagnosis.
What they do
Develops AI powered software designed to analyze echocardiograms, improving the accuracy of heart failure and coronary artery disease detection. The software is used by hospital systems and cardiologists to standardize ultrasound interpretation and reduce diagnostic errors.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Echocardiography analysis AI
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2017
- Total funding
- $50M raised
Notable investors: Blue Venture Fund, Optum Ventures, Oxford Science Enterprises, LDV Partners.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBAThe HealthTech Signal
At-home semen analysis is turning a taboo test into a routine one
At-home semen analysis is turning a taboo test into a routine one
Dr. Dereck Mush, MD, MBA
Who Is Liable When AI Clinical Decision Support Gives Bad Advice?
Dr. Dereck Mush, MD, MBA
When Medical Devices Start a Conversation: Inside Penn’s Epilepsy Study
Dr. Dereck Mush, MD, MBA